Insmed

Ultime notizie

Titoli nella lingua originale della fonte.

• Insmed Incorporated (INSM) stock price, news, quote and history (si apre in una nuova scheda)

  Yahoo Finance UK · 1 ott 2026

• Insmed | 10/1/26 (si apre in una nuova scheda)

  ktnv.com · 1 ott 2026

• Insmed Price Target Cut to $207.00/Share From $237.00 by Barclays (si apre in una nuova scheda)

  Moomoo · 30 set 2026

• Barclays Maintains Insmed(INSM.US) With Buy Rating, Cuts Target Price to $207 (si apre in una nuova scheda)

  Moomoo · 30 set 2026

• Insmed TPIP shows sustained improvement in PAH study (si apre in una nuova scheda)

  scanx.trade · 28 set 2026

• Insmed 15-year return: $1,000 investment grows to $27,361 (si apre in una nuova scheda)

  scanx.trade · 28 set 2026

• $1000 Invested In Insmed 15 Years Ago Would Be Worth This Much Today (si apre in una nuova scheda)

  Benzinga · 28 set 2026

• Insmed (INSM) Gets Faster FDA Review. Can Its Lung Drug Reach More Patients? (si apre in una nuova scheda)

  Yahoo Finance · 28 set 2026

• Insmed (INSM) Could Be 40% Undervalued On FDA Priority Review News (si apre in una nuova scheda)

  Simply Wall Street · 28 set 2026

• Why Insmed (INSM) Stock Is Down Today (si apre in una nuova scheda)

  Quiver Quantitative · 25 set 2026

• Goldman Sachs initiates Insmed stock coverage with buy rating, $188 target (si apre in una nuova scheda)

  Investing.com · 24 set 2026

• Learn Why The Bull Case For Insmed Stock Could Change Following Priority Review Acceptance (si apre in una nuova scheda)

  Simply Wall Street · 23 set 2026

• FDA grants priority review to Insmed's Arikayce sNDA for MAC lung disease (si apre in una nuova scheda)

  Dealroom · 22 set 2026

• Insmed's Brinsupri hits $517M sales; strong pip... (si apre in una nuova scheda)

  Pluang · 22 set 2026

• FDA Accepts Insmed's Filing Seeking Label Expansion for Arikayce (si apre in una nuova scheda)

  Yahoo Finance · 22 set 2026

• Insmed: Expensive Stock, But Discount To Recent Highs Makes Bull Case (NASDAQ:INSM) (si apre in una nuova scheda)

  Seeking Alpha · 22 set 2026

• Insmed stock price target maintained at $195 by Mizuho on FDA review (si apre in una nuova scheda)

  Investing.com · 22 set 2026

• Discipline and Rules-Based Execution in INSM Response (si apre in una nuova scheda)

  Stock Traders Daily · 22 set 2026

• FDA Grants Priority Review To Insmed's SNDA For Arikayce For Treatment Of Mac Lung Disease With PDUFA Target Action Date Set For January 28, 2027 (si apre in una nuova scheda)

  TradingView · 21 set 2026

• Insmed receives FDA Priority Review for MAC lung therapy after stock ends session down 3% (si apre in una nuova scheda)

  Traders Union · 21 set 2026

• Insmed Incorporated (INSM) Stock Report: A Biotech Powerhouse with 66% Potential Upside (si apre in una nuova scheda)

  DirectorsTalk Interviews · 21 set 2026

• FDA Grants Priority Review to Insmed's sNDA for ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of MAC Lung Disease With PDUFA Target Action Date Set for January 28, 2027 (si apre in una nuova scheda)

  Insmed Incorporated Investor Relations · 21 set 2026

• Insmed Says FDA Grants Priority Review to Arikayce Supplemental Filing for MAC Lung Disease (si apre in una nuova scheda)

  Yahoo Finance · 21 set 2026

• Insmed stock rises on FDA priority review for Arikayce (si apre in una nuova scheda)

  Investing.com · 21 set 2026

• Did FDA Priority Review of ARIKAYCE ENCORE Data Just Shift Insmed's (INSM) Investment Narrative? (si apre in una nuova scheda)

  Yahoo Finance · 21 set 2026

• Why is Insmed stock climbing today? (si apre in una nuova scheda)

  Investing.com · 21 set 2026

• Insmed stock slips after strong earnings surprise and rich valuation debate (si apre in una nuova scheda)

  AD HOC NEWS · 19 set 2026

• The Fund Exited Insmed (INSM) After the Investment Thesis Played Out (si apre in una nuova scheda)

  Yahoo Finance · 16 set 2026

• Insmed Expands Community Impact During Fifth Annual Global Day of Good (si apre in una nuova scheda)

  Yahoo Finance · 16 set 2026

• 1,350 employees help 50 nonprofits in one day. Insmed volunteers log 15,000 hours. (si apre in una nuova scheda)

  Stock Titan · 16 set 2026